Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDMD Baird Medical Investment	$2.30 +15.0%	$3.35	$1.05 ▼ $12.50	$71.46M	-1	277,906 shs	419,459 shs
MODD Modular Medical	$0.72 +2.8%	$0.73	$0.63 ▼ $2.65	$38.70M	0.17	71,643 shs	227,689 shs
PSTV Plus Therapeutics	$0.49 +0.6%	$0.44	$0.16 ▼ $2.31	$47.94M	0.67	15.22 million shs	5.25 million shs
TELA TELA Bio	$1.77 +2.9%	$1.84	$0.86 ▼ $3.26	$68.14M	0.93	94,801 shs	97,402 shs

The Best High-Yield Dividend Stocks for 2025

Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDMD Baird Medical Investment	-2.44%	-22.48%	-7.83%	-59.18%	+199,999,900.00%
MODD Modular Medical	-1.32%	-5.01%	+0.01%	-17.91%	-58.08%
PSTV Plus Therapeutics	-0.12%	-10.92%	+13.65%	+61.54%	-66.92%
TELA TELA Bio	+1.78%	+7.50%	-9.95%	+19.44%	-42.67%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MODD Modular Medical	0.2039 of 5 stars	0.0	3.0	0.0	0.0	0.0	1.7	0.0
PSTV Plus Therapeutics	2.8533 of 5 stars	3.3	5.0	0.0	0.0	2.8	0.0	0.6
TELA TELA Bio	3.1645 of 5 stars	3.3	4.0	0.0	0.0	3.5	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BDMD Baird Medical Investment	0.00	N/A	N/A	N/A
MODD Modular Medical	0.00	N/A	N/A	N/A
PSTV Plus Therapeutics	2.60	Moderate Buy	$8.88	1,727.26% Upside
TELA TELA Bio	2.50	Moderate Buy	$4.50	154.24% Upside

Current Analyst Ratings Breakdown

Latest PSTV, MODD, TELA, and BDMD Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2025	PSTV Plus Therapeutics	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$4.00 ➝ $3.00
6/27/2025	PSTV Plus Therapeutics	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$5.50 ➝ $3.00
6/25/2025	PSTV Plus Therapeutics	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold	$9.00
6/5/2025	PSTV Plus Therapeutics	Ascendiant Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$20.00 ➝ $20.50

(Data available from 8/22/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A	N/A
MODD Modular Medical	N/A	N/A	N/A	N/A	$0.21 per share	N/A
PSTV Plus Therapeutics	$5.82M	8.28	N/A	N/A	$0.03 per share	16.19
TELA TELA Bio	$69.30M	1.01	N/A	N/A	$0.23 per share	7.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BDMD Baird Medical Investment	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
MODD Modular Medical	-$18.82M	-$0.51	N/A	∞	N/A	N/A	-185.60%	-158.95%	N/A
PSTV Plus Therapeutics	-$12.98M	-$2.24	N/A	N/A	N/A	-357.85%	N/A	-117.72%	N/A
TELA TELA Bio	-$37.84M	-$1.12	N/A	N/A	N/A	-54.12%	-329.48%	-57.34%	11/6/2025 (Estimated)

Latest PSTV, MODD, TELA, and BDMD Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q1 2026	MODD Modular Medical	-$0.10	-$0.12	-$0.02	-$0.12	$0.20 million	N/A
8/14/2025	Q2 2025	PSTV Plus Therapeutics	-$0.09	-$0.01	+$0.08	-$0.01	$1.08 million	$1.39 million
8/11/2025	Q2 2025	TELA TELA Bio	-$0.18	-$0.22	-$0.04	-$0.22	$20.67 million	$20.20 million
6/20/2025	Q4 2025	MODD Modular Medical	-$0.11	-$0.12	-$0.01	-$0.12	N/A	N/A
5/30/2025	Q1 2025	PSTV Plus Therapeutics	-$0.17	-$0.56	-$0.39	-$1.19	$1.11 million	$1.06 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BDMD Baird Medical Investment	N/A	N/A	N/A	N/A	N/A
MODD Modular Medical	N/A	N/A	N/A	N/A	N/A
PSTV Plus Therapeutics	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BDMD Baird Medical Investment	N/A	N/A	N/A
MODD Modular Medical	N/A	4.04	10.69
PSTV Plus Therapeutics	N/A	1.26	1.03
TELA TELA Bio	4.14	3.19	2.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BDMD Baird Medical Investment	19.78%
MODD Modular Medical	27.47%
PSTV Plus Therapeutics	3.28%
TELA TELA Bio	94.35%

Insider Ownership

Company	Insider Ownership
BDMD Baird Medical Investment	78.90%
MODD Modular Medical	20.46%
PSTV Plus Therapeutics	0.79%
TELA TELA Bio	4.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BDMD Baird Medical Investment	N/A	35.73 million	7.54 million	N/A
MODD Modular Medical	20	55.28 million	43.97 million	Not Optionable
PSTV Plus Therapeutics	20	99.26 million	60.01 million	Not Optionable
TELA TELA Bio	120	39.62 million	37.75 million	Optionable

PSTV, MODD, TELA, and BDMD Headlines

Recent News About These Companies

Aroa Biosurgery Reports Strong Growth and Expands Product Range Amid Market Challenges

August 20 at 4:34 AM | msn.com

Tela Bio reports Q2 EPS (22c), consensus (19c)

August 13, 2025 | msn.com

TELA Bio (NASDAQ:TELA) Issues Earnings Results

August 12, 2025 | marketbeat.com

Tela Bio backs FY25 revenue view $85M-$88M, consensus $86.05M

August 12, 2025 | msn.com

Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates

August 12, 2025 | msn.com

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2025 | zacks.com

TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript

August 11, 2025 | seekingalpha.com

TELA Bio Reports Second Quarter 2025 Financial Results

August 11, 2025 | globenewswire.com

TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect

August 10, 2025 | finance.yahoo.com

TELA Bio Awards Inducement Equity Grants to New Employees

August 10, 2025 | msn.com

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 8, 2025 | globenewswire.com

TELA Bio (TELA) Expected to Announce Quarterly Earnings on Monday

August 5, 2025 | marketbeat.com

TELA Bio (NASDAQ:TELA) Trading 4.2% Higher - Time to Buy?

July 30, 2025 | marketbeat.com

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 23, 2025 | globenewswire.com

AIGH Capital Management LLC Sells 1,246,462 Shares of TELA Bio, Inc. (NASDAQ:TELA)

July 22, 2025 | marketbeat.com

TELA Bio to Announce Second Quarter 2025 Financial Results

July 21, 2025 | globenewswire.com

TELA Bio, Inc. (TELA) Latest Stock News & Headlines - Yahoo Finance

July 19, 2025 | finance.yahoo.com

Breakeven On The Horizon For TELA Bio, Inc. (NASDAQ:TELA)

July 3, 2025 | finance.yahoo.com

TELA Bio Welcomes Jim Hagen with Strategic Equity Grant

June 9, 2025 | msn.com

TELA Bio, Inc.: TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 7, 2025 | finanznachrichten.de

TELA Bio, Inc. Grants Inducement Equity Awards to New Senior Vice President Jim Hagen

June 6, 2025 | quiverquant.comQ

New MarketBeat Followers Over Time

Media Sentiment Over Time

PSTV, MODD, TELA, and BDMD Company Descriptions

Baird Medical Investment NASDAQ:BDMD

$2.30 +0.30 (+15.00%)

As of 04:00 PM Eastern

Baird Medical Investment Holdings Ltd. is a medical technology company, which engages in the development and provision of medical devices. It is also involved in the design, development, manufacturing, and sale of microwave ablation medical devices, as well as sale of other medical devices. The company was founded on June 16, 2023 and is headquartered in Guangzhou, China.

Modular Medical NASDAQ:MODD

$0.72 +0.02 (+2.84%)

Closing price 04:00 PM Eastern

Extended Trading

$0.73 +0.01 (+1.39%)

As of 05:00 PM Eastern

Modular Medical, Inc. operates as a medical device company. It focuses on the design, development, and commercialization of insulin pumps. It offers MODD1, a two-part patch pump for type-1 and type-2 diabetes. The company is headquartered in San Diego, California.

Plus Therapeutics NASDAQ:PSTV

$0.49 +0.00 (+0.56%)

Closing price 04:00 PM Eastern

Extended Trading

$0.47 -0.01 (-2.61%)

As of 07:59 PM Eastern

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

TELA Bio NASDAQ:TELA

$1.77 +0.05 (+2.91%)

Closing price 04:00 PM Eastern

Extended Trading

$1.78 +0.01 (+0.56%)

As of 04:10 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time